BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home
»
Newsletters
» BioWorld
BioWorld
April 16, 2003
View Archived Issues
Tumor Cells Lurk In Transplanted Organ, Wreak Kaposi's Sarcoma, Frequent Transplant Malignancy
Read More
Third Acadia, Allergan Deal Has Potential For More Than $32M
Read More
Biotech, Pharma Companies Continue Refining Relationships
Read More
International Consortium Finishes Full Sequence Of Human Genome
Read More
CancerVax Resuming Phase III Trials Of Canvaxin In Melanoma
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
GenVec Plans Merger With Diacrin Through $40M Stock Transaction
Not to compare the biotechnology industry - with its blockbuster drugs and groundbreaking science - with a flea market, but there are good deals in this depressed environment if you look around. (BioWorld Today)
Read More
Sequencing Headway On SARS Could Lead To Critical Vaccine
Read More
